N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells

N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lai, Jie, Zhou, Zhiyong, Hu, Kan, Yu, HongLong, Su, Xingyao, Niu, Xiaoqiang, Li, Huizi, Mao, Shengxun
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Lai, Jie
Zhou, Zhiyong
Hu, Kan
Yu, HongLong
Su, Xingyao
Niu, Xiaoqiang
Li, Huizi
Mao, Shengxun
description N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immune infiltration by regulating the related expression of tumour genes. However, the role of m6A modification in colorectal cancer (CRC) drug resistance is unclear. Here, MeRIP-seq and RNA-seq techniques were utilized to obtain mRNA, lncRNA expression, and their methylation profiles in 5-Fluorouracil (5-FU)-resistant colon cancer HCT-15 cells and control cells. In addition, we performed detailed bioinformatics analysis as well as in vitro experiments of lncRNA to explore the function of lncRNA with differential m6A in CRC progression and drug resistance. In this study, we obtained the m6A methylomic landscape of CRC cells and resistance group cells by MeRIP-seq and RNA-seq. We identified 3698 differential m6A peaks, of which 2224 were hypermethylated, and 1474 were hypomethylated. Among the lncRNAs, 60 were hypermethylated, and 38 were hypomethylated. GO and KEGG analysis annotations showed significant enrichment of endocytosis and MAPK signalling pathways. Moreover, knockdown of lncRNA ADIRF-AS1 and AL139035.1 promoted CRC proliferation and invasive metastasis in vitro. lncRNA- mRNA network showed that ADIRF-AS1 and AL139035.1 May play a key role in regulating drug resistance formation. We provide the first m6A methylation profile in 5-FU resistance CRC cells and analyse the functions of differential m6A-modified mRNAs and lncRNAs. Our results indicated that differential m6A RNAs were significantly associated with MAPK signalling and endocytosis after induction of 5-FU resistance. Knockdown of LncRNA ADIRF-AS1 and AL139035.1 promotes CRC progression and might be critical in regulating drug resistance formation. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance.This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance. This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs.
doi_str_mv 10.6084/m9.figshare.24902705
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_24902705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_24902705</sourcerecordid><originalsourceid>FETCH-LOGICAL-d915-9276086e4b70729361ae406c23469738b41e069993c64053b920da513ec921243</originalsourceid><addsrcrecordid>eNo1kL1OAzEQhN1QoMAbUPgFfPjvfHEZRQSQoiChUFs-ey-x5B90dpO354CkmhnN7mr1IfTEaKfoWj4n3U3hVM92ho5LTflA-3uUDookaOdLtB5yqSEDvuYWSsY223ipoeIy4VjyCeeSXfFhcZ-HTV16j9OfCxn3ZPdFZljGm80Nu7JsYGezgxk7iLE-oLvJxgqPV12h4-7luH0j-4_X9-1mT7xmPdF8WD5WIMeBDlwLxSxIqhwXUulBrEfJgCqttXBK0l6MmlNveybAac64FCsk_89626wLDcz3HJKdL4ZR8wvDJG1uMMwNhvgBhelaNQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells</title><source>DataCite</source><creator>Lai, Jie ; Zhou, Zhiyong ; Hu, Kan ; Yu, HongLong ; Su, Xingyao ; Niu, Xiaoqiang ; Li, Huizi ; Mao, Shengxun</creator><creatorcontrib>Lai, Jie ; Zhou, Zhiyong ; Hu, Kan ; Yu, HongLong ; Su, Xingyao ; Niu, Xiaoqiang ; Li, Huizi ; Mao, Shengxun</creatorcontrib><description>N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immune infiltration by regulating the related expression of tumour genes. However, the role of m6A modification in colorectal cancer (CRC) drug resistance is unclear. Here, MeRIP-seq and RNA-seq techniques were utilized to obtain mRNA, lncRNA expression, and their methylation profiles in 5-Fluorouracil (5-FU)-resistant colon cancer HCT-15 cells and control cells. In addition, we performed detailed bioinformatics analysis as well as in vitro experiments of lncRNA to explore the function of lncRNA with differential m6A in CRC progression and drug resistance. In this study, we obtained the m6A methylomic landscape of CRC cells and resistance group cells by MeRIP-seq and RNA-seq. We identified 3698 differential m6A peaks, of which 2224 were hypermethylated, and 1474 were hypomethylated. Among the lncRNAs, 60 were hypermethylated, and 38 were hypomethylated. GO and KEGG analysis annotations showed significant enrichment of endocytosis and MAPK signalling pathways. Moreover, knockdown of lncRNA ADIRF-AS1 and AL139035.1 promoted CRC proliferation and invasive metastasis in vitro. lncRNA- mRNA network showed that ADIRF-AS1 and AL139035.1 May play a key role in regulating drug resistance formation. We provide the first m6A methylation profile in 5-FU resistance CRC cells and analyse the functions of differential m6A-modified mRNAs and lncRNAs. Our results indicated that differential m6A RNAs were significantly associated with MAPK signalling and endocytosis after induction of 5-FU resistance. Knockdown of LncRNA ADIRF-AS1 and AL139035.1 promotes CRC progression and might be critical in regulating drug resistance formation. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance.This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance. This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs.</description><identifier>DOI: 10.6084/m9.figshare.24902705</identifier><language>eng</language><publisher>Taylor &amp; Francis</publisher><subject>Biological Sciences not elsewhere classified ; Cancer ; Cell Biology ; FOS: Biological sciences ; Genetics ; Hematology ; Molecular Biology ; Pharmacology</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>781,1895</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.24902705$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lai, Jie</creatorcontrib><creatorcontrib>Zhou, Zhiyong</creatorcontrib><creatorcontrib>Hu, Kan</creatorcontrib><creatorcontrib>Yu, HongLong</creatorcontrib><creatorcontrib>Su, Xingyao</creatorcontrib><creatorcontrib>Niu, Xiaoqiang</creatorcontrib><creatorcontrib>Li, Huizi</creatorcontrib><creatorcontrib>Mao, Shengxun</creatorcontrib><title>N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells</title><description>N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immune infiltration by regulating the related expression of tumour genes. However, the role of m6A modification in colorectal cancer (CRC) drug resistance is unclear. Here, MeRIP-seq and RNA-seq techniques were utilized to obtain mRNA, lncRNA expression, and their methylation profiles in 5-Fluorouracil (5-FU)-resistant colon cancer HCT-15 cells and control cells. In addition, we performed detailed bioinformatics analysis as well as in vitro experiments of lncRNA to explore the function of lncRNA with differential m6A in CRC progression and drug resistance. In this study, we obtained the m6A methylomic landscape of CRC cells and resistance group cells by MeRIP-seq and RNA-seq. We identified 3698 differential m6A peaks, of which 2224 were hypermethylated, and 1474 were hypomethylated. Among the lncRNAs, 60 were hypermethylated, and 38 were hypomethylated. GO and KEGG analysis annotations showed significant enrichment of endocytosis and MAPK signalling pathways. Moreover, knockdown of lncRNA ADIRF-AS1 and AL139035.1 promoted CRC proliferation and invasive metastasis in vitro. lncRNA- mRNA network showed that ADIRF-AS1 and AL139035.1 May play a key role in regulating drug resistance formation. We provide the first m6A methylation profile in 5-FU resistance CRC cells and analyse the functions of differential m6A-modified mRNAs and lncRNAs. Our results indicated that differential m6A RNAs were significantly associated with MAPK signalling and endocytosis after induction of 5-FU resistance. Knockdown of LncRNA ADIRF-AS1 and AL139035.1 promotes CRC progression and might be critical in regulating drug resistance formation. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance.This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance. This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs.</description><subject>Biological Sciences not elsewhere classified</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>FOS: Biological sciences</subject><subject>Genetics</subject><subject>Hematology</subject><subject>Molecular Biology</subject><subject>Pharmacology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kL1OAzEQhN1QoMAbUPgFfPjvfHEZRQSQoiChUFs-ey-x5B90dpO354CkmhnN7mr1IfTEaKfoWj4n3U3hVM92ho5LTflA-3uUDookaOdLtB5yqSEDvuYWSsY223ipoeIy4VjyCeeSXfFhcZ-HTV16j9OfCxn3ZPdFZljGm80Nu7JsYGezgxk7iLE-oLvJxgqPV12h4-7luH0j-4_X9-1mT7xmPdF8WD5WIMeBDlwLxSxIqhwXUulBrEfJgCqttXBK0l6MmlNveybAac64FCsk_89626wLDcz3HJKdL4ZR8wvDJG1uMMwNhvgBhelaNQ</recordid><startdate>20231225</startdate><enddate>20231225</enddate><creator>Lai, Jie</creator><creator>Zhou, Zhiyong</creator><creator>Hu, Kan</creator><creator>Yu, HongLong</creator><creator>Su, Xingyao</creator><creator>Niu, Xiaoqiang</creator><creator>Li, Huizi</creator><creator>Mao, Shengxun</creator><general>Taylor &amp; Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20231225</creationdate><title>N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells</title><author>Lai, Jie ; Zhou, Zhiyong ; Hu, Kan ; Yu, HongLong ; Su, Xingyao ; Niu, Xiaoqiang ; Li, Huizi ; Mao, Shengxun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d915-9276086e4b70729361ae406c23469738b41e069993c64053b920da513ec921243</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biological Sciences not elsewhere classified</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>FOS: Biological sciences</topic><topic>Genetics</topic><topic>Hematology</topic><topic>Molecular Biology</topic><topic>Pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Lai, Jie</creatorcontrib><creatorcontrib>Zhou, Zhiyong</creatorcontrib><creatorcontrib>Hu, Kan</creatorcontrib><creatorcontrib>Yu, HongLong</creatorcontrib><creatorcontrib>Su, Xingyao</creatorcontrib><creatorcontrib>Niu, Xiaoqiang</creatorcontrib><creatorcontrib>Li, Huizi</creatorcontrib><creatorcontrib>Mao, Shengxun</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lai, Jie</au><au>Zhou, Zhiyong</au><au>Hu, Kan</au><au>Yu, HongLong</au><au>Su, Xingyao</au><au>Niu, Xiaoqiang</au><au>Li, Huizi</au><au>Mao, Shengxun</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells</title><date>2023-12-25</date><risdate>2023</risdate><abstract>N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immune infiltration by regulating the related expression of tumour genes. However, the role of m6A modification in colorectal cancer (CRC) drug resistance is unclear. Here, MeRIP-seq and RNA-seq techniques were utilized to obtain mRNA, lncRNA expression, and their methylation profiles in 5-Fluorouracil (5-FU)-resistant colon cancer HCT-15 cells and control cells. In addition, we performed detailed bioinformatics analysis as well as in vitro experiments of lncRNA to explore the function of lncRNA with differential m6A in CRC progression and drug resistance. In this study, we obtained the m6A methylomic landscape of CRC cells and resistance group cells by MeRIP-seq and RNA-seq. We identified 3698 differential m6A peaks, of which 2224 were hypermethylated, and 1474 were hypomethylated. Among the lncRNAs, 60 were hypermethylated, and 38 were hypomethylated. GO and KEGG analysis annotations showed significant enrichment of endocytosis and MAPK signalling pathways. Moreover, knockdown of lncRNA ADIRF-AS1 and AL139035.1 promoted CRC proliferation and invasive metastasis in vitro. lncRNA- mRNA network showed that ADIRF-AS1 and AL139035.1 May play a key role in regulating drug resistance formation. We provide the first m6A methylation profile in 5-FU resistance CRC cells and analyse the functions of differential m6A-modified mRNAs and lncRNAs. Our results indicated that differential m6A RNAs were significantly associated with MAPK signalling and endocytosis after induction of 5-FU resistance. Knockdown of LncRNA ADIRF-AS1 and AL139035.1 promotes CRC progression and might be critical in regulating drug resistance formation. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance.This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance. This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs.</abstract><pub>Taylor &amp; Francis</pub><doi>10.6084/m9.figshare.24902705</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.24902705
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_24902705
source DataCite
subjects Biological Sciences not elsewhere classified
Cancer
Cell Biology
FOS: Biological sciences
Genetics
Hematology
Molecular Biology
Pharmacology
title N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T05%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Lai,%20Jie&rft.date=2023-12-25&rft_id=info:doi/10.6084/m9.figshare.24902705&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_24902705%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true